Lib Therapeutics, Inc.
1 products tracked · names used in filings: Lib Therapeutics, Inc.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 12 Dec 2025🇺🇸 FDA approval
FDA approves Lerochol (lerodalcibep-liga), a new medicine
Lib Therapeutics, Inc.; BLA761427; New biologic; injectable · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Lerochol lerodalcibep-liga | Approved | 2025-12-12 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.